|
|
||||||||
The Journal of Neurophysiology Vol. 83 No. 6 June 2000, pp. 3287-3293
Copyright ©2000 by the American Physiological Society
1Laboratoire de Neurobiologie et Neuropharmacologie du Developpement, Institut des Neurosciences, Centre National de la Recherche Scientifique-Université Paris VI, 75005 Paris; and 2Sanofi Recherche, 34184 Montpellier, France
Auclair, Nathalie,
Satoru Otani,
Philippe Soubrie, and
Francis Crepel.
Cannabinoids Modulate Synaptic Strength and Plasticity at
Glutamatergic Synapses of Rat Prefrontal Cortex Pyramidal Neurons. J. Neurophysiol. 83: 3287-3293, 2000. Cannabinoids receptors have been reported to modulate synaptic
transmission in many structures of the CNS, but yet little is known
about their role in the prefrontal cortex where type I cannabinoid
receptor (CB-1) are expressed. In this study, we tested first the acute
effects of selective agonists and antagonist of CB-1 on glutamatergic
excitatory postsynaptic currents (EPSCs) in slices of rat prefrontal
cortex (PFC). EPSCs were evoked in patch-clamped layer V pyramidal
cells by stimulation of layer V afferents. Monosynaptic EPSCs were
strongly depressed by bath application (1 µM) of the cannabinoid
receptors agonists WIN55212-2 (
50.4 ± 8.8%) and CP55940
(
42.4 ± 10.9%). The CB-1 antagonist SR141716A reversed these
effects. Unexpectedly, SR141716A alone produced a significant increase
of glutamatergic synaptic transmission (+46.9 ± 11.2%), which
could be partly reversed by WIN55212-2. In the presence of strontium in
the bath, the frequency but not the amplitude of asynchronous synaptic
events evoked in layer V pyramidal cells by stimulating layer V
afferents, was markedly decreased (
54.2 ± 8%), indicating a
presynaptic site of action of cannabinoids at these synapses. Tetanic
stimulation (100 pulses at 100 Hz, 4 trains) induced in control
condition, no changes (n = 7/18), long-term depression
(LTD; n = 6/18), or long-term potentiation (LTP;
n = 5/18) of monosynaptic EPSCs evoked by stimulation of layer V afferents. When tetanus was applied in the presence of WIN
55,212-2 or SR141716-A (1 µM) in the bath, the proportion of
"nonplastic" cells were not significantly changed
(n = 7/15 in both cases). For the plastic ones
(n = 8 in both cases), WIN 55,212-2 strongly favored
LTD (n = 7/8) at the apparent expense of LTP
(n = 1/8), whereas the opposite effect was observed
with SR141716-A (7/8 LTP; 1/8 LTD). These results demonstrate that cannabinoids influence glutamatergic synaptic transmission and plasticity in the PFC of rodent.
This article has been cited by other articles:
![]() |
S. Haj-Dahmane and R.-Y. Shen Endocannabinoids Suppress Excitatory Synaptic Transmission to Dorsal Raphe Serotonin Neurons through the Activation of Presynaptic CB1 Receptors J. Pharmacol. Exp. Ther., October 1, 2009; 331(1): 186 - 196. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Azad, J. Kurz, G. Marsicano, B. Lutz, W. Zieglgansberger, and G. Rammes Activation of CB1 specifically located on GABAergic interneurons inhibits LTD in the lateral amygdala Learn. Mem., March 5, 2008; 15(3): 143 - 152. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Zhu and D. M. Lovinger Persistent Synaptic Activity Produces Long-Lasting Enhancement of Endocannabinoid Modulation and Alters Long-Term Synaptic Plasticity J Neurophysiol, June 1, 2007; 97(6): 4386 - 4389. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Fong, X.-M. Guan, D. J. Marsh, C.-P. Shen, D. S. Stribling, K. M. Rosko, J. Lao, H. Yu, Y. Feng, J. C. Xiao, et al. Antiobesity Efficacy of a Novel Cannabinoid-1 Receptor Inverse Agonist, N-[(1S,2S)-3-(4-Chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-{[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (MK-0364), in Rodents J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 1013 - 1022. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Hill, T. Gallopin, I. Ferezou, B. Cauli, J. Rossier, P. Schweitzer, and B. Lambolez Functional CB1 Receptors Are Broadly Expressed in Neocortical GABAergic and Glutamatergic Neurons J Neurophysiol, April 1, 2007; 97(4): 2580 - 2589. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Fortin and E. S. Levine Differential Effects of Endocannabinoids on Glutamatergic and GABAergic Inputs to Layer 5 Pyramidal Neurons Cereb Cortex, January 1, 2007; 17(1): 163 - 174. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Eggan and D. A. Lewis Immunocytochemical Distribution of the Cannabinoid CB1 Receptor in the Primate Neocortex: A Regional and Laminar Analysis Cereb Cortex, January 1, 2007; 17(1): 175 - 191. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Tasker, S. Di, and R. Malcher-Lopes Rapid Glucocorticoid Signaling via Membrane-Associated Receptors Endocrinology, December 1, 2006; 147(12): 5549 - 5556. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sang and C. Chen Lipid Signaling and Synaptic Plasticity Neuroscientist, October 1, 2006; 12(5): 425 - 434. [Abstract] [PDF] |
||||
![]() |
M. R. Domenici, S. C. Azad, G. Marsicano, A. Schierloh, C. T. Wotjak, H.-U. Dodt, W. Zieglgansberger, B. Lutz, and G. Rammes Cannabinoid Receptor Type 1 Located on Presynaptic Terminals of Principal Neurons in the Forebrain Controls Glutamatergic Synaptic Transmission J. Neurosci., May 24, 2006; 26(21): 5794 - 5799. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A. Bender, K. J. Bender, D. J. Brasier, and D. E. Feldman Two coincidence detectors for spike timing-dependent plasticity in somatosensory cortex. J. Neurosci., April 19, 2006; 26(16): 4166 - 4177. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Antonelli, M. C. Tomasini, M. Tattoli, T. Cassano, S. Tanganelli, S. Finetti, E. Mazzoni, L. Trabace, L. Steardo, V. Cuomo, et al. Prenatal Exposure to the CB1 Receptor Agonist WIN 55,212-2 Causes Learning Disruption Associated with Impaired Cortical NMDA Receptor Function and Emotional Reactivity Changes in Rat Offspring Cereb Cortex, December 1, 2005; 15(12): 2013 - 2020. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Tasker, S. Di, and R. Malcher-Lopes Rapid Central Corticosteroid Effects: Evidence for Membrane Glucocorticoid Receptors in the Brain Integr. Comp. Biol., August 1, 2005; 45(4): 665 - 671. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wang, I. M. Hitron, C. Iadecola, and V. M. Pickel Synaptic and Vascular Associations of Neurons Containing Cyclooxygenase-2 and Nitric Oxide Synthase in Rat Somatosensory Cortex Cereb Cortex, August 1, 2005; 15(8): 1250 - 1260. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Sharkey and Q. J. Pittman Central and Peripheral Signaling Mechanisms Involved in Endocannabinoid Regulation of Feeding: A Perspective on the Munchies Sci. Signal., March 29, 2005; 2005(277): pe15 - pe15. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Haj-Dahmane and R.-Y. Shen The Wake-Promoting Peptide Orexin-B Inhibits Glutamatergic Transmission to Dorsal Raphe Nucleus Serotonin Neurons through Retrograde Endocannabinoid Signaling J. Neurosci., January 26, 2005; 25(4): 896 - 905. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Fortin, J. Trettel, and E. S. Levine Brief Trains of Action Potentials Enhance Pyramidal Neuron Excitability Via Endocannabinoid-Mediated Suppression of Inhibition J Neurophysiol, October 1, 2004; 92(4): 2105 - 2112. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-C. Liang, C.-C. Huang, K.-S. Hsu, and T. Takahashi Cannabinoid-induced presynaptic inhibition at the primary afferent trigeminal synapse of juvenile rat brainstem slices J. Physiol., February 15, 2004; 555(1): 85 - 96. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Melis, M. Pistis, S. Perra, A. L. Muntoni, G. Pillolla, and G. L. Gessa Endocannabinoids Mediate Presynaptic Inhibition of Glutamatergic Transmission in Rat Ventral Tegmental Area Dopamine Neurons through Activation of CB1 Receptors J. Neurosci., January 7, 2004; 24(1): 53 - 62. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Patel, D. J. Rademacher, and C. J. Hillard Differential Regulation of the Endocannabinoids Anandamide and 2-Arachidonylglycerol within the Limbic Forebrain by Dopamine Receptor Activity J. Pharmacol. Exp. Ther., September 1, 2003; 306(3): 880 - 888. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. F. FREUND, I. KATONA, and D. PIOMELLI Role of Endogenous Cannabinoids in Synaptic Signaling Physiol Rev, July 1, 2003; 83(3): 1017 - 1066. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Di, R. Malcher-Lopes, K. Cs. Halmos, and J. G. Tasker Nongenomic Glucocorticoid Inhibition via Endocannabinoid Release in the Hypothalamus: A Fast Feedback Mechanism J. Neurosci., June 15, 2003; 23(12): 4850 - 4857. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Rademacher, S. Patel, F. A. Hopp, C. Dean, C. J. Hillard, and J. L. Seagard Microinjection of a cannabinoid receptor antagonist into the NTS increases baroreflex duration in dogs Am J Physiol Heart Circ Physiol, May 1, 2003; 284(5): H1570 - H1576. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Azad, M. Eder, G. Marsicano, B. Lutz, W. Zieglgansberger, and G. Rammes Activation of the Cannabinoid Receptor Type 1 Decreases Glutamatergic and GABAergic Synaptic Transmission in the Lateral Amygdala of the Mouse Learn. Mem., March 1, 2003; 10(2): 116 - 128. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Ploner, A. Tschirch, F. Ostendorf, S. Dick, B. M. Gaymard, S. Rivaud-Pechoux, F. Sporkert, F. Pragst, and A. M. Stadelmann Oculomotor Effects of {delta}-9-Tetrahydrocannabinol in Humans: Implications for the Functional Neuroanatomy of the Brain Cannabinoid System Cereb Cortex, October 1, 2002; 12(10): 1016 - 1023. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Trettel and E. S. Levine Cannabinoids Depress Inhibitory Synaptic Inputs Received by Layer 2/3 Pyramidal Neurons of the Neocortex J Neurophysiol, July 1, 2002; 88(1): 534 - 539. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Robbe, M. Kopf, A. Remaury, J. Bockaert, and O. J. Manzoni Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens PNAS, June 11, 2002; 99(12): 8384 - 8388. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Howlett, F. Barth, T. I. Bonner, G. Cabral, P. Casellas, W. A. Devane, C. C. Felder, M. Herkenham, K. Mackie, B. R. Martin, et al. International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors Pharmacol. Rev., June 1, 2002; 54(2): 161 - 202. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-C. Huang, Y.-L. Chen, S.-W. Lo, and K.-S. Hsu Activation of cAMP-Dependent Protein Kinase Suppresses the Presynaptic Cannabinoid Inhibition of Glutamatergic Transmission at Corticostriatal Synapses Mol. Pharmacol., March 1, 2002; 61(3): 578 - 585. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ferraro, M. C. Tomasini, G. L. Gessa, B. W. Bebe, S. Tanganelli, and T. Antonelli The Cannabinoid Receptor Agonist WIN 55,212-2 Regulates Glutamate Transmission in Rat Cerebral Cortex: an In Vivo and In Vitro Study Cereb Cortex, August 1, 2001; 11(8): 728 - 733. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-C. Huang, S.-W. Lo, and K.-S. Hsu Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons J. Physiol., May 1, 2001; 532(3): 731 - 748. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Rodriguez, K. Mackie, and V. M. Pickel Ultrastructural Localization of the CB1 Cannabinoid Receptor in {micro}-Opioid Receptor Patches of the Rat Caudate Putamen Nucleus J. Neurosci., February 1, 2001; 21(3): 823 - 833. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Robbe, G. Alonso, F. Duchamp, J. Bockaert, and O. J. Manzoni Localization and Mechanisms of Action of Cannabinoid Receptors at the Glutamatergic Synapses of the Mouse Nucleus Accumbens J. Neurosci., January 1, 2001; 21(1): 109 - 116. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |